BVXV logo

BiondVax Pharmaceuticals (BVXV) Cash From Investing

Annual CFI

-$836.00 K
-$697.00 K-501.44%

December 31, 2022

Summary

Performance

1-Year Change

-501.44%

3-Year Change

+59.79%

5-Year Change

-142.99%

15-Year Change

-142.99%

BVXV Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.94 M
BVXV annual cash flow from investing activities is currently -142.99% below its historical high of $1.94 million

3-Year Low

-$836.00 K
BVXV annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BVXV previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BVXV next annual earnings announcement has not yet been scheduled

OtherBVXVcash flowmetrics:

Annual CFF

$6.78 M
BVXV annual cash flow from financing activities is $6.78 million

Annual CFO

-$7.26 M
BVXV annual cash flow from operations is -$7.26 million

Annual FCF

-$8.10 M
BVXV annual free cash flow is -$8.10 million

Annual CAPEX

-
BVXV annual capital expenditures value is unknown

Quarterly CFI

-$377.00 K
-$371.00 K-6183.33%

June 30, 2023

Summary

Performance

3-Month Change

-6183.33%

1-Year Change

-1177.14%

3-Year Change

-

5-Year Change

+77.84%

BVXV Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.58 M
BVXV quarterly cash flow from investing activities is currently -123.85% below its historical high of $1.58 million

3-Year Low

-$521.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BVXV previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BVXV next earnings announcement has not yet been scheduled

OtherBVXVcash flowmetrics:

Quarterly CFF

$0.00
BVXV quarterly cash flow from financing activities is $0.00

Quarterly CFO

-$2.88 M
BVXV quarterly cash flow from operations is -$2.88 million

Quarterly FCF

-$3.25 M
BVXV quarterly free cash flow is -$3.25 million

Quarterly CAPEX

-
BVXV quarterly capital expenditures value is unknown

TTM CFI

-$383.00 K
-$412.00 K-1420.69%

June 30, 2023

Summary

Performance

3-Month Change

-1420.69%

1-Year Change

+21.19%

3-Year Change

-

5-Year Change

-

BVXV TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.68 M
BVXV TTM cash flow from investing activities is currently -110.41% below its historical high of $3.68 million

3-Year Low

-$521.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BVXV previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BVXV next earnings announcement has not yet been scheduled

OtherBVXVcash flowmetrics:

TTM CFF

$0.00
BVXV TTM cash flow from financing activities is $0.00

TTM CFO

-$5.93 M
BVXV TTM cash flow from operations is -$5.93 million

TTM FCF

-$6.32 M
BVXV TTM free cash flow is -$6.32 million

TTM CAPEX

-
BVXV TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BVXV Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-501.4%-1177.1%+21.2%
3 y3 years+59.8%--
5 y5 years-143.0%+77.8%-

BVXV Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+501.4%at low-1177.1%+38.2%-1420.7%+36.0%
5 y5-year+501.4%+148.7%-1177.1%+38.2%-1420.7%+36.0%
alltimeall time-143.0%+644.9%-123.8%+704.8%-110.4%+1561.7%

BiondVax Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2023
-
-$377.00 K(+6183.3%)
-$383.00 K(-1420.7%)
Mar 2023
-
-$6000.00(-117.1%)
$29.00 K(-106.0%)
Dec 2022
-$836.00 K(+501.4%)
-
-
Jun 2022
-
$35.00 K(-106.7%)
-$486.00 K(-6.7%)
Mar 2022
-
-$521.00 K(+100.2%)
-$521.00 K(-85.6%)
Dec 2021
-$139.00 K(-92.5%)
-
-
Dec 2020
-$1.85 M(-11.2%)
-
-
Dec 2019
-$2.08 M(-66.6%)
-
-
Jun 2019
-
-$260.30 K(-70.2%)
-$3.62 M(-28.5%)
Mar 2019
-
-$872.10 K(+8.4%)
-$5.06 M(-18.8%)
Dec 2018
-$6.23 M(-420.2%)
-$804.50 K(-52.1%)
-$6.23 M(-2.2%)
Sep 2018
-
-$1.68 M(-1.3%)
-$6.36 M(+76.1%)
Jun 2018
-
-$1.70 M(-16.7%)
-$3.61 M(+986.7%)
Mar 2018
-
-$2.04 M(+117.0%)
-$332.60 K(-117.1%)
Dec 2017
$1.94 M
-$941.40 K(-187.9%)
$1.94 M(-47.2%)
Sep 2017
-
$1.07 M(-32.2%)
$3.68 M(+30.4%)
DateAnnualQuarterlyTTM
Jun 2017
-
$1.58 M(+575.6%)
$2.82 M(-257.5%)
Mar 2017
-
$234.00 K(-70.5%)
-$1.79 M(-11.8%)
Dec 2016
-$2.03 M(>+9900.0%)
$794.30 K(+272.0%)
-$2.03 M(-26.0%)
Sep 2016
-
$213.50 K(-107.0%)
-$2.75 M(-9.7%)
Jun 2016
-
-$3.03 M(>+9900.0%)
-$3.04 M(>+9900.0%)
Mar 2016
-
-$4800.00(-106.1%)
-$15.80 K(+43.6%)
Dec 2015
-$11.00 K(-76.2%)
$79.10 K(-198.9%)
-$11.00 K(-87.5%)
Sep 2015
-
-$80.00 K(+692.1%)
-$87.80 K(+1525.9%)
Jun 2015
-
-$10.10 K(<-9900.0%)
-$5400.00(-258.8%)
Mar 2015
-
$0.00(-100.0%)
$3400.00(-107.3%)
Dec 2014
-$46.20 K(-107.9%)
$2300.00(-4.2%)
-$46.30 K(-4.7%)
Sep 2014
-
$2400.00(-284.6%)
-$48.60 K(-4.7%)
Jun 2014
-
-$1300.00(-97.4%)
-$51.00 K(+2.6%)
Mar 2014
-
-$49.70 K
-$49.70 K
Dec 2013
$581.20 K(-618.0%)
-
-
Dec 2012
-$112.20 K(-84.6%)
-
-
Dec 2011
-$730.20 K
-
-

FAQ

  • What is BiondVax Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals annual CFI year-on-year change?
  • What is BiondVax Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals quarterly CFI year-on-year change?
  • What is BiondVax Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals TTM CFI year-on-year change?

What is BiondVax Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of BVXV is -$836.00 K

What is the all time high annual CFI for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high annual cash flow from investing activities is $1.94 M

What is BiondVax Pharmaceuticals annual CFI year-on-year change?

Over the past year, BVXV annual cash flow from investing activities has changed by -$697.00 K (-501.44%)

What is BiondVax Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of BVXV is -$377.00 K

What is the all time high quarterly CFI for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high quarterly cash flow from investing activities is $1.58 M

What is BiondVax Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, BVXV quarterly cash flow from investing activities has changed by -$412.00 K (-1177.14%)

What is BiondVax Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of BVXV is -$383.00 K

What is the all time high TTM CFI for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high TTM cash flow from investing activities is $3.68 M

What is BiondVax Pharmaceuticals TTM CFI year-on-year change?

Over the past year, BVXV TTM cash flow from investing activities has changed by +$103.00 K (+21.19%)